Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges and Clinical Advances
Amidst revenue decline and significant cash burn, Durect Corp reports promising clinical trial results and strategic FDA interactions. May 14, 2024
GuruFocus Research Drug Manufacturers
Vext Science Inc (VEXTF) Q4 2023 Earnings Call Transcript Highlights: Navigating Market Challenges and Strategic Expansions
Despite a slight revenue dip, Vext Science Inc (VEXTF) strengthens its market position with strategic expansions and robust operational strategies. May 13, 2024
GuruFocus Research Drug Manufacturers
ANI Pharmaceuticals Inc (ANIP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Expansions
ANI Pharmaceuticals reports a significant revenue increase and strategic advancements in its Q1 2024 earnings, setting a positive trajectory for the year. May 13, 2024
GuruFocus Research Drug Manufacturers
Silver Spike Investment Corp (SSIC) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Capitalizing on Opportunities
Despite a challenging quarter marked by transaction expenses, SSIC maintains a robust investment pipeline and declares a steady dividend. May 13, 2024